AL-01811

N/A

Report date: 2023/01/22 18:40:39

Base Information

Drug NameAL-01811
Drug Alias NameAL-01811
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionβ-glucosidase inhibitors
Targetsβ-glucosidase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlectos Therapeutics
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A